Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y006771 | — |
no adverse event; one dose of PROQUAD with temperature excursion was inadvertently administered; This spontaneous report was received from an office manager and refers to a identified patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was inadvertently administered a 0.5 mL dose of improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y006771, expiration date: 24-Sep-2025) for prophylaxis. The administered dose of the vaccine experienced several temperature excursions as follows: On 09-AUG-2024: -10°C up to 8°C (-9.3C) for 1 hours, 53 minutes; on 29-SEP-2024: -14°C up to -10°C (-13.6C) for 30 minutes; on 16-JUN-2025: -14°C up to -10°C (-14.4C) for 9 minutes. The patient did not experienced any adverse event. This is one of two reports received from the same source.; Reporter's Comments: Keywords : MUL
MERCK STERILE DILUENT